Inhibitors of AKT activity

The present invention is directed to compounds which contain substituted pyridazines and pyrimidines moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and method...

Full description

Saved in:
Bibliographic Details
Main Author BILODEAU MARK T.,CHUA PETER C.,COSFORD NICHOLAS D. P.,HOFFMAN JACOB M.,NAGASAWA JOHNNY YASUO
Format Patent
LanguageEnglish
Published 04.04.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to compounds which contain substituted pyridazines and pyrimidines moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
Bibliography:Application Number: CN200580011976